Preparation and Biological Activity of the Monoclonal Antibody against the Second Extracellular Loop of the Angiotensin II Type 1 Receptor

The current study was to prepare a mouse-derived antibody against the angiotensin II type 1 receptor (AT1-mAb) based on monoclonal antibody technology, to provide a foundation for research on AT1-AA-positive diseases. Balb/C mice were actively immunized with the second extracellular loop of the angi...

Full description

Saved in:
Bibliographic Details
Main Authors: Mingming Wei, Chengrui Zhao, Suli Zhang, Li Wang, Huirong Liu, Xinliang Ma
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2016/1858252
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850222846984323072
author Mingming Wei
Chengrui Zhao
Suli Zhang
Li Wang
Huirong Liu
Xinliang Ma
author_facet Mingming Wei
Chengrui Zhao
Suli Zhang
Li Wang
Huirong Liu
Xinliang Ma
author_sort Mingming Wei
collection DOAJ
description The current study was to prepare a mouse-derived antibody against the angiotensin II type 1 receptor (AT1-mAb) based on monoclonal antibody technology, to provide a foundation for research on AT1-AA-positive diseases. Balb/C mice were actively immunized with the second extracellular loop of the angiotensin II type 1 receptor (AT1R-ECII). Then, mouse spleen lymphocytes were fused with myeloma cells and monoclonal hybridomas that secreted AT1-mAb were generated and cultured, after which those in logarithmic-phase were injected into the abdominal cavity of mice to retrieve the ascites. Highly purified AT1-mAb was isolated from mouse ascites after injection with 1 × 107 hybridomas. A greater amount of AT1-mAb was purified from mouse ascites compared to the cell supernatant of hybridomas. AT1-mAb purified from mouse ascites constricted the thoracic aorta of mice and increased the beat frequency of neonatal rat myocardial cells via the AT1R, identical to the effects of AT1-AA extracted from patients’ sera. Murine blood pressure increased after intravenous injection of AT1-mAb via the tail vein. High purity and good biological activity of AT1-mAb can be obtained from mouse ascites after intraperitoneal injection of monoclonal hybridomas that secrete AT1-mAb. These data provide a simple tool for studying AT1-AA-positive diseases.
format Article
id doaj-art-6d679d756abb40b9b944e387a14d4dc3
institution OA Journals
issn 2314-8861
2314-7156
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-6d679d756abb40b9b944e387a14d4dc32025-08-20T02:06:12ZengWileyJournal of Immunology Research2314-88612314-71562016-01-01201610.1155/2016/18582521858252Preparation and Biological Activity of the Monoclonal Antibody against the Second Extracellular Loop of the Angiotensin II Type 1 ReceptorMingming Wei0Chengrui Zhao1Suli Zhang2Li Wang3Huirong Liu4Xinliang Ma5Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, ChinaDepartment of Physiology, Basic Medical Department, Fenyang College of Shanxi Medical University, Fenyang, Shanxi 032200, ChinaDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, ChinaDepartment of Pathology, Shanxi Medical University, Taiyuan, Shanxi 030001, ChinaDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, ChinaDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, ChinaThe current study was to prepare a mouse-derived antibody against the angiotensin II type 1 receptor (AT1-mAb) based on monoclonal antibody technology, to provide a foundation for research on AT1-AA-positive diseases. Balb/C mice were actively immunized with the second extracellular loop of the angiotensin II type 1 receptor (AT1R-ECII). Then, mouse spleen lymphocytes were fused with myeloma cells and monoclonal hybridomas that secreted AT1-mAb were generated and cultured, after which those in logarithmic-phase were injected into the abdominal cavity of mice to retrieve the ascites. Highly purified AT1-mAb was isolated from mouse ascites after injection with 1 × 107 hybridomas. A greater amount of AT1-mAb was purified from mouse ascites compared to the cell supernatant of hybridomas. AT1-mAb purified from mouse ascites constricted the thoracic aorta of mice and increased the beat frequency of neonatal rat myocardial cells via the AT1R, identical to the effects of AT1-AA extracted from patients’ sera. Murine blood pressure increased after intravenous injection of AT1-mAb via the tail vein. High purity and good biological activity of AT1-mAb can be obtained from mouse ascites after intraperitoneal injection of monoclonal hybridomas that secrete AT1-mAb. These data provide a simple tool for studying AT1-AA-positive diseases.http://dx.doi.org/10.1155/2016/1858252
spellingShingle Mingming Wei
Chengrui Zhao
Suli Zhang
Li Wang
Huirong Liu
Xinliang Ma
Preparation and Biological Activity of the Monoclonal Antibody against the Second Extracellular Loop of the Angiotensin II Type 1 Receptor
Journal of Immunology Research
title Preparation and Biological Activity of the Monoclonal Antibody against the Second Extracellular Loop of the Angiotensin II Type 1 Receptor
title_full Preparation and Biological Activity of the Monoclonal Antibody against the Second Extracellular Loop of the Angiotensin II Type 1 Receptor
title_fullStr Preparation and Biological Activity of the Monoclonal Antibody against the Second Extracellular Loop of the Angiotensin II Type 1 Receptor
title_full_unstemmed Preparation and Biological Activity of the Monoclonal Antibody against the Second Extracellular Loop of the Angiotensin II Type 1 Receptor
title_short Preparation and Biological Activity of the Monoclonal Antibody against the Second Extracellular Loop of the Angiotensin II Type 1 Receptor
title_sort preparation and biological activity of the monoclonal antibody against the second extracellular loop of the angiotensin ii type 1 receptor
url http://dx.doi.org/10.1155/2016/1858252
work_keys_str_mv AT mingmingwei preparationandbiologicalactivityofthemonoclonalantibodyagainstthesecondextracellularloopoftheangiotensiniitype1receptor
AT chengruizhao preparationandbiologicalactivityofthemonoclonalantibodyagainstthesecondextracellularloopoftheangiotensiniitype1receptor
AT sulizhang preparationandbiologicalactivityofthemonoclonalantibodyagainstthesecondextracellularloopoftheangiotensiniitype1receptor
AT liwang preparationandbiologicalactivityofthemonoclonalantibodyagainstthesecondextracellularloopoftheangiotensiniitype1receptor
AT huirongliu preparationandbiologicalactivityofthemonoclonalantibodyagainstthesecondextracellularloopoftheangiotensiniitype1receptor
AT xinliangma preparationandbiologicalactivityofthemonoclonalantibodyagainstthesecondextracellularloopoftheangiotensiniitype1receptor